BioProcess Technology Consultants Adds Key Staffers as It Continues Rapid Growth

New consultants deepen BPTC’s capabilities in critical areas

WOBURN, Mass.--()--BioProcess Technology Consultants Inc., the leading provider of Chemistry, Manufacturing and Controls (CMC) services in the global life sciences industry, announced it has hired two additional consultants as it continues to grow and expand its service offerings.

The new employees bring BPTC’s consulting staff to a total of 21 and underscore the firm’s commitment to providing an expanding range of technical, regulatory and strategic assistance to pharmaceutical and biotechnology companies as they develop and commercialize biopharmaceutical products.

“These new members of the BPTC team strengthen our capabilities in analytical methods development, quality control, and regulatory services,” said Howard L. Levine, Ph.D., president and CEO of BPTC. “These areas are becoming more complex as biopharmaceutical companies seek to advance product candidates from clone to clinic to commercialization.”

New members of the BPTC team include:

Sonit Tomar, Ph.D. Dr. Tomar is the former associate director of analytical development and technical operations at Epirus Biopharmaceuticals. At Epirus, Dr. Tomar was responsible for biosimilar characterization and comparability studies. He previously worked at Genzyme and MassBiologics. His skill set includes bioprocess development, analytical methods and formulation development, comparability, quality control, technology transfer, and CMC regulatory issues. He earned his Ph.D. from the Polytechnic Institute of New York University.

Arvilla Trag. Prior to joining BPTC, Ms. Trag led her own consulting company where she specialized in preparing INDs, CMC sections of BLAs, investigator brochures and informed consent forms for clients ranging from startups to multi-national biopharmaceutical companies. She has conducted more than 250 cGMP compliance audits of contract manufacturers and testing labs, performed due diligence for M&A, and performed gap analyses of quality systems. She previously held senior positions at Biopure and Virogenetics.

“BPTC continues to grow to serve the expanding needs of biopharmaceutical clients,” said Dr. Levine. “These new additions to our consulting staff provide additional depth to our existing staff and provide additional resources to assist our clients in navigating their CMC challenges. This will help them advance their product candidates more effectively and more efficiently.”

About BioProcess Technology Consultants

Founded in 1994, BioProcess Technology Consultants is the recognized worldwide leader in biologics Chemistry, Manufacturing, and Controls (CMC) consulting, providing a full range of technical, regulatory, and strategic assistance to pharmaceutical and biotechnology companies in the development and commercialization of biopharmaceutical products. The company works with clients globally to find and apply solutions to the challenges of biopharmaceutical product development from clone to commercial®. BPTC helps develop manufacturing processes and strategies that enhance the overall value of client companies and accelerate the advancement of new products from clone to clinic®. BPTC also helps investors make informed decisions by providing technical and business evaluations of new products and technologies and product discovery, development, and commercialization plans of potential investments and existing portfolio companies. For more information about BPTC, visit http://www.bptc.com. Folllow us on Twitter at @bptcGlobal and LinkedIn at https://www.linkedin.com/company-beta/510782.

Contacts

BioProcess Technology Consultants Inc.
Al Doig, 781-281-1869
adoig@bptc.com

Release Summary

BioProcess Technology Consultants adds staff as it grows to help life science companies move drug candidates from clone to clinic to commercial.

Contacts

BioProcess Technology Consultants Inc.
Al Doig, 781-281-1869
adoig@bptc.com